Exact Sciences Corporation EXAS NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Diagnostics & Research • US • USD

SharesGrow Score

36/100

1/7 Pass

SharesGrow Intrinsic Value

Exact Sciences Corporation (EXAS) has 20 known insider and institutional holders on record. The largest holder is Zanotti Katherine S with 75,966 shares. Other notable holders include Paulsen Gisela and Doyle James Edward.

Over the last 12 months, insiders have made 43 transactions in EXAS stock — 19 buys (valued at $13.89K) and 1 sells (valued at $170.61K). Insider buying has outpaced selling during this period, which may signal confidence in the company's prospects.

EXAS Insider Ownership

Top Holder

Zanotti Katherine S

75,966 shares

Buys (12 mo)

$13.89K value

Sells (12 mo)

$170.61K value

12-Month Transaction Activity

Buy 44%

Sell 2%

Top Insider Holders

#	Name	Role	Shares Owned	Last Filed	Relative Size
1	Zanotti Katherine S	Director	75,966	2025-06-16	100%
2	Paulsen Gisela	Gen Mgr, Precision Oncology	66,267	2020-04-22	87%
3	Doyle James Edward	Director	61,447	2025-06-16	81%
4	Coward D Scott	Director	57,562	2025-06-16	76%
5	Cunningham Everett	Chief Commercial Officer	46,470	2024-05-02	61%
6	Orville Jacob A	EVP, GM, Screening	38,707	2026-02-27	51%
7	Lidgard Graham Peter	Chief Science Officer	34,891	2021-03-10	46%
8	Levangie Daniel J	Director	34,312	2025-06-16	45%
9	Sebelius Kathleen	Director	32,671	2024-12-20	43%
10	Baranick Brian	EVP, GM, Precision Oncology	28,063	2026-02-27	37%
11	Bloomer Aaron	EVP, Chief Financial Officer	28,063	2026-02-27	37%
12	Clancy Paul J	Director	26,038	2025-06-16	34%
13	Stenhouse Mark	President, Cologuard	25,000	2020-04-06	33%
14	Jacquet Pierre	Director	23,576	2023-06-12	31%
15	Condella Sarah	EVP, Human Resources	23,224	2026-02-27	31%
16	Petrovic Shacey	Director	21,804	2025-06-16	29%
17	Herriott James	SVP, General Counsel & Sec	20,321	2026-02-27	27%
18	Lewis-hall Freda C	Director	19,688	2023-06-12	26%
19	Conroy Kevin T	President and CEO	18,143	2026-03-03	24%
20	Trigg Leslie	Director	17,169	2025-06-16	23%

Recent Transactions (last 12 months)

Date	Name	Role	Type	Shares	Price	Value
2026-03-23	Bloomer Aaron	EVP, Chief Financial Officer	Return of Shares	28,063	-	-
2026-03-23	Herriott James	SVP, General Counsel & Sec	Return of Shares	20,321	-	-
2026-03-23	Baranick Brian	EVP, GM, Precision Oncology	Return of Shares	28,063	-	-
2026-03-23	Barber Michael J	Director	Return of Shares	7,422	-	-
2026-03-23	Condella Sarah	EVP, Human Resources	Return of Shares	23,224	-	-
2026-03-23	Petrovic Shacey	Director	Return of Shares	7,095	$0.01	$70.95
2026-03-23	Doyle James Edward	Director	Return of Shares	5,398	-	-
2026-03-23	Clancy Paul J	Director	Return of Shares	5,398	-	-
2026-03-23	Zanotti Katherine S	Director	Return of Shares	5,398	-	-
2026-03-23	Popovits Kimberly J	Director	Return of Shares	9,656	-	-
2026-03-23	Conroy Kevin T	President and CEO	Return of Shares	154,829	-	-
2026-03-23	Trigg Leslie	Director	Return of Shares	13,925	-	-
2026-03-23	Orville Jacob A	EVP, GM, Screening	Return of Shares	38,707	-	-
2026-03-23	Coward D Scott	Director	Return of Shares	12,875	$98.18	$1.26M
2026-02-27	Condella Sarah	EVP, Human Resources	Option Exercise (Sell)	3,900	$5.03	$19.62K
2026-02-27	Conroy Kevin T	President and CEO	Option Exercise (Sell)	18,143	-	-
2026-02-25	Bloomer Aaron	EVP, Chief Financial Officer	RSU Award	28,063	-	-
2026-02-25	Herriott James	SVP, General Counsel & Sec	RSU Award	20,321	-	-
2026-02-25	Baranick Brian	EVP, GM, Precision Oncology	RSU Award	28,063	-	-
2026-02-25	Condella Sarah	EVP, Human Resources	RSU Award	23,224	-	-
2026-02-25	Conroy Kevin T	President and CEO	RSU Award	154,829	-	-
2026-02-25	Orville Jacob A	EVP, GM, Screening	RSU Award	38,707	-	-
2025-12-24	Baranick Brian	EVP, GM, Precision Oncology	Tax Withholding of RSU	14,938	$101.59	$1.52M
2025-12-23	Baranick Brian	EVP, GM, Precision Oncology	Option Exercise	9,450	-	-
2025-12-23	Orville Jacob A	EVP, GM, Screening	Option Exercise (Sell)	16,051	-	-